2016
Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study
Hruska CB, Scott CG, Conners AL, Whaley DH, Rhodes DJ, Carter RE, O’Connor M, Hunt KN, Brandt KR, Vachon CM. Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study. Breast Cancer Research 2016, 18: 42. PMID: 27113363, PMCID: PMC4845425, DOI: 10.1186/s13058-016-0704-6.Peer-Reviewed Original ResearchConceptsBackground parenchymal uptakeCase-control studyBreast cancer casesRisk factorsBreast cancerCancer casesParenchymal uptakeIncident breast cancer casesBreast cancer risk factorsRetrospective case-control studyDense breastsConditional logistic regression analysisInvasive breast cancer casesPostmenopausal hormone useCancer risk factorsFunctional imaging biomarkersBreast cancer riskLogistic regression analysisBI-RADS densityPostmenopausal womenEligible womenMenopausal statusHormone useMedian ageSupplemental screening
2015
Background parenchymal uptake during molecular breast imaging and associated clinical factors.
Hruska CB, Rhodes DJ, Conners AL, Jones KN, Carter RE, Lingineni RK, Vachon CM. Background parenchymal uptake during molecular breast imaging and associated clinical factors. American Journal Of Roentgenology 2015, 204: w363-70. PMID: 25714323, PMCID: PMC4423612, DOI: 10.2214/ajr.14.12979.Peer-Reviewed Original ResearchMeSH KeywordsBreast DensityBreast NeoplasmsFemaleHumansMammary Glands, HumanMiddle AgedMolecular ImagingRadionuclide ImagingRetrospective StudiesConceptsBackground parenchymal uptakePostmenopausal hormone therapyParenchymal uptakeBreast cancerMolecular breast imagingHormone therapyClinical factorsMammographic densityDense breastsBI-RADS density categoriesChi-square testMenopausal statusPatient characteristicsHormonal contraceptivesEligible participantsGail modelMenstrual cycleSubsequent riskPrevious mammogramsMolecular breastBreast implantsUnderlying causeCancerBreastWomen